Utilization of Palliative Radiation in Pediatric Oncology Patients During the End-of-life (EOL)
Abstract Background Suffering at the end-of-life (EOL) can impact the perception of a “good death” and ultimately affect bereavement for
Integrative medicine in oncology: redefining the standard of care
Integrative medicine incorporated alongside cancer care, referred to as integrative oncology, is an evidence-informed field with established clinical guidelines. Although
Precision oncology across the ages: Impact on children, adolescents, and young adults
Abstract: Precision oncology endeavors to tailor therapies based on individual patient and tumor characteristics. This rapidly evolving field has transformed
Immunotherapies for Childhood Cancer
Abstract Children are surviving cancer in greater numbers than ever. Over the last 50 years, substantial advancements in pediatric cancer
Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations
Abstract Pleuropulmonary blastoma (PPB) is a rare cancer occurring mainly during early childhood and often associated with germline DICER1 mutations. It is
Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendations
Abstract Pancreatoblastoma (PBL) is a rare malignant epithelial neoplasm that affects typically young children. Signs related to advanced upper-abdominal tumor
Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents
Abstract As part of the European Union-funded project designated Paediatric Rare Tumours Network – European Registry (PARTNER), the European Cooperative
Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations
Abstract Adrenocortical tumours (ACTs) are rare during childhood. A complete surgical resection provides the best chance of cure, but the
Cutaneous melanoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations
Abstract Cutaneous melanoma is rare in children and, like other very rare pediatric tumors, it suffers from a shortage of
